Literature DB >> 3584393

Gonadal dysfunction in diabetic men with organic impotence.

F T Murray, H U Wyss, R G Thomas, M Spevack, A G Glaros.   

Abstract

Previous studies of the relationship of gonadal function to impotence in men with diabetes mellitus have yielded conflicting results. Pituitary-testicular function was studied in 28 impotent diabetic men and 15 normal men. Impotence was documented by clinical history and subdivided into categories of primary organic (n = 16), primary psychogenic (n = 7), and unclassified (n = 5) on the basis of nocturnal penile tumescence (NPT) testing, psychological testing, and penile vascular studies. All NPT parameters were diminished (P less than or equal to 0.001) in the impotent diabetic men compared to values in the normal men. Endocrine studies revealed increased urinary LH (P less than or equal to 0.05) and diminished serum free testosterone levels in the diabetic men with primary organic impotence. These changes were not found in normal men or diabetic men with primary psychogenic impotence. Six months of treatment in a home blood glucose-monitoring program resulted in significant improvement in metabolic control but no improvement in pituitary-testicular function, NPT, or sexual performance in the primary organic impotent group. Eight patients with primary organic impotence and no evidence of penile vascular disease had significant improvement (P less than or equal to 0.01) in NPT results as well as subjective improvement in sexual function after 6 months of parenteral testosterone administration. These studies suggest that primary gonadal dysfunction may be related to organic impotence in diabetes, and improvement in selected patients can occur with androgen therapy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584393     DOI: 10.1210/jcem-65-1-127

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  An evaluation of the Minnesota Multiphasic Personality Inventory as a discriminator of primary organic and primary psychogenic impotence in diabetic males.

Authors:  T W Jefferson; A Glaros; M Spevack; T L Boaz; F T Murray
Journal:  Arch Sex Behav       Date:  1989-04

2.  Multifactorial evaluation of diabetic erectile dysfunction.

Authors:  O Kayigil; O Atahan; A Metin
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

3.  In vitro biological-to-immunological ratio of serum gonadotropins throughout male puberty in children with insulin-dependent diabetes mellitus.

Authors:  Elisa Nishimura; Daniela Söderlund; Cecilia Castro-Fernández; Teresa Zariñán; Juan Pablo Méndez; Alfredo Ulloa-Aguirre
Journal:  Endocrine       Date:  2007-02       Impact factor: 3.633

4.  The effect of DA-8159 on corpus cavernosal smooth muscle relaxation and penile erection in diabetic rabbits.

Authors:  Kyung Koo Kang; Seul Min Choi; Gook Jun Ahn; Jong Won Kwon; Won Bae Kim
Journal:  Urol Res       Date:  2004-03-13

5.  Reproductive endocrinopathy in acute streptozotocin-induced diabetic male rats. Studies on LHRH.

Authors:  R W Clough; S G Kienast; R W Steger
Journal:  Endocrine       Date:  1998-02       Impact factor: 3.633

Review 6.  Testosterone, diabetes mellitus, and the metabolic syndrome.

Authors:  Richard F Spark
Journal:  Curr Urol Rep       Date:  2007-11       Impact factor: 2.862

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.